Gene · 3664
Papers2,069
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,069
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The ELF3 transcription factor is associated with an epithelial phenotype and represses epithelial-mesenchymal transition. | J Biol Eng | 2023 | 36864480 | PubTator, text mining | PubMed |
| Single visit rehabilitation of 12-day neonate with cleft palate using modified feeding spoon impression technique: A case report. | Clin Case Rep | 2023 | 36860725 | PubTator, text mining | PubMed |
| B-Cell Epitope Mapping of the Plasmodium falciparum Malaria Vaccine Candidate GMZ2.6c in a Naturally Exposed Population of the Brazilian Amazon. | Vaccines (Basel) | 2023 | 36851323 | PubTator, text mining | PubMed |
| The IRF6 AP-2α binding site polymorphism relate to the severity of non-syndromic orofacial cleft of Indonesian patients. | Minerva Dent Oral Sci | 2023 | 36847740 | PubTator, text mining | PubMed |
| GRHL2 and AP2a coordinate early surface ectoderm lineage commitment during development. | iScience | 2023 | 36843855 | PubTator, text mining | PubMed |
| Immune activation of vaginal human Langerhans cells increases susceptibility to HIV-1 infection. | Sci Rep | 2023 | 36841916 | PubTator, text mining | PubMed |
| Regulation of Physiological Barrier Function by the Commensal Microbiota. | Life (Basel) | 2023 | 36836753 | PubTator, text mining | PubMed |
| Complexification of In Vitro Models of Intestinal Barriers, A True Challenge for a More Accurate Alternative Approach. | Int J Mol Sci | 2023 | 36835003 | PubTator, text mining | PubMed |
| Ultra-Rare Variants Identify Biological Pathways and Candidate Genes in the Pathobiology of Non-Syndromic Cleft Palate Only. | Biomolecules | 2023 | 36830605 | PubTator, text mining | PubMed |
| Immunity in Sea Turtles: Review of a Host-Pathogen Arms Race Millions of Years in the Running. | Animals (Basel) | 2023 | 36830343 | PubTator, text mining | PubMed |
| Novel Prognostic Biomarkers for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Patients via Analysis of Competing Endogenous RNA (ceRNA) Network. | Dis Markers | 2023 | 36817087 | PubTator, text mining | PubMed |
| Novel IRF6 variant in orofacial cleft patients from Durban, South Africa. | Mol Genet Genomic Med | 2023 | 36811272 | PubTator, text mining | PubMed |
| Heterogeneity and plasticity of epithelial-mesenchymal transition (EMT) in cancer metastasis: Focusing on partial EMT and regulatory mechanisms. | Cell Prolif | 2023 | 36808651 | PubTator, text mining | PubMed |
| Expression, regulating mechanism and therapeutic target of KIF20A in multiple cancer. | Heliyon | 2023 | 36798768 | PubTator, text mining | PubMed |
| Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosis. | Front Genet | 2023 | 36793897 | PubTator, text mining | PubMed |
| The Functional Meaning of 5'UTR in Protein-Coding Genes. | Int J Mol Sci | 2023 | 36769304 | PubTator, text mining | PubMed |
| The NOTCH-RIPK4-IRF6-ELOVL4 Axis Suppresses Squamous Cell Carcinoma. | Cancers (Basel) | 2023 | 36765696 | PubTator, text mining | PubMed |
| Morphometric analysis of the size-adjusted linear dimensions of the skull landmarks revealed craniofacial dysmorphology in Mid1-cKO mice. | BMC Genomics | 2023 | 36759768 | PubTator, text mining | PubMed |
| Development and evaluation of a multiplex serodiagnostic bead assay (BurkPx) for accurate melioidosis diagnosis. | PLoS Negl Trop Dis | 2023 | 36753506 | PubTator, text mining | PubMed |
| Differences in clinical characteristics and outcomes between patients with grade 3a and grades 1-2 follicular lymphoma: a real-world multicenter study. | Biomark Res | 2023 | 36747226 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3664/papers?page=14